• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原与中性粒细胞比值作为甲状腺乳头状癌合并2型糖尿病患者中央区淋巴结转移的新预测指标

Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus.

作者信息

Zheng Danni, Yang Jiawen, Qian Jiali, Jin Lingli, Huang Guanli

机构信息

Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.

出版信息

Cancer Manag Res. 2022 Dec 20;14:3493-3505. doi: 10.2147/CMAR.S366270. eCollection 2022.

DOI:10.2147/CMAR.S366270
PMID:36573167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9789701/
Abstract

BACKGROUND

Many patients have a higher risk of thyroid cancer if they have both papillary thyroid carcinoma (PTC) and Type 2 diabetes mellitus (T2DM). Meanwhile, the primary reason for local PTC recurrence is cervical lymph node metastasis. Therefore, the prognosis of patients affects how cervical lymph nodes are managed during surgery. Due to surgical complications such as laryngeal nerve palsy and hypocalcemia, it is still debatable whether to prevent central lymph node dissection (CLND). Predicting central lymph node metastasis (CLNM) is crucial to direct CLND. It is unclear how important the fibrinogen-to-neutrophil ratio (FNR) is in thyroid cancer, so we looked into how it might help patients with PTC and T2DM predict CLNM.

PATIENTS AND METHODS

Wenzhou Medical University's First Affiliated Hospital provided us with 413 patients with PTC and T2DM, randomly divided into a training set (N = 292) and a validation set (N = 121). Univariate and multivariate logistic regression analyses were used to identify independent risk factors. After constructing a nomogram, the validity of the model was evaluated.

RESULTS

The maximum tumor diameter, high-density lipoprotein, thyroxine, triglyceride, lymphocyte, and FNR were all identified as independent risk factors by multivariate logistic regression analysis. The C index of the training set was 0.775, and the validation set was 0.654.

CONCLUSION

In patients with PTC and T2DM, preoperative FNR was an independent risk factor for CLNM.

摘要

背景

许多同时患有甲状腺乳头状癌(PTC)和2型糖尿病(T2DM)的患者患甲状腺癌的风险更高。同时,PTC局部复发的主要原因是颈部淋巴结转移。因此,患者的预后会影响手术中颈部淋巴结的处理方式。由于存在喉返神经麻痹和低钙血症等手术并发症,对于是否进行中央区淋巴结清扫(CLND)仍存在争议。预测中央区淋巴结转移(CLNM)对于指导CLND至关重要。目前尚不清楚纤维蛋白原与中性粒细胞比值(FNR)在甲状腺癌中的重要性如何,因此我们研究了它如何帮助PTC和T2DM患者预测CLNM。

患者与方法

温州医科大学附属第一医院为我们提供了413例PTC和T2DM患者,随机分为训练集(N = 292)和验证集(N = 121)。采用单因素和多因素逻辑回归分析确定独立危险因素。构建列线图后,评估模型的有效性。

结果

多因素逻辑回归分析确定最大肿瘤直径、高密度脂蛋白、甲状腺素、甘油三酯、淋巴细胞和FNR均为独立危险因素。训练集的C指数为0.775,验证集为0.654。

结论

在PTC和T2DM患者中,术前FNR是CLNM的独立危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/4c5d624b3514/CMAR-14-3493-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/383e1a7c0cff/CMAR-14-3493-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/a4d075ab69d1/CMAR-14-3493-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/6106073855e7/CMAR-14-3493-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/ec57b4734584/CMAR-14-3493-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/4c5d624b3514/CMAR-14-3493-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/383e1a7c0cff/CMAR-14-3493-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/a4d075ab69d1/CMAR-14-3493-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/6106073855e7/CMAR-14-3493-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/ec57b4734584/CMAR-14-3493-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0ae/9789701/4c5d624b3514/CMAR-14-3493-g0005.jpg

相似文献

1
Fibrinogen-to-Neutrophil Ratio as a New Predictor of Central Lymph Node Metastasis in Patients with Papillary Thyroid Cancer and Type 2 Diabetes Mellitus.纤维蛋白原与中性粒细胞比值作为甲状腺乳头状癌合并2型糖尿病患者中央区淋巴结转移的新预测指标
Cancer Manag Res. 2022 Dec 20;14:3493-3505. doi: 10.2147/CMAR.S366270. eCollection 2022.
2
Development and validation of a nomogram for preoperative prediction of ipsilateral cervical central lymph node metastasis in papillary thyroid cancer: a population-based study.甲状腺乳头状癌同侧颈中央区淋巴结转移术前预测列线图的开发与验证:一项基于人群的研究
Gland Surg. 2024 Apr 29;13(4):528-539. doi: 10.21037/gs-23-478. Epub 2024 Apr 22.
3
Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).预测甲状腺乳头状癌(cN0)中央颈部淋巴结转移的预测因子和预测模型。
Front Endocrinol (Lausanne). 2022 Jan 27;12:789310. doi: 10.3389/fendo.2021.789310. eCollection 2021.
4
Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.术前预测 cN0T1/T2 期甲状腺乳头状癌中央区淋巴结转移:基于临床和超声特征的列线图
Eur J Surg Oncol. 2022 Jun;48(6):1272-1279. doi: 10.1016/j.ejso.2022.04.001. Epub 2022 Apr 6.
5
Development and Validation of a Nomogram for Preoperative Prediction of Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma and Type 2 Diabetes Mellitus.甲状腺乳头状癌合并2型糖尿病患者中央区淋巴结转移术前预测列线图的开发与验证
Cancer Manag Res. 2021 Mar 17;13:2499-2513. doi: 10.2147/CMAR.S300264. eCollection 2021.
6
Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography.甲状腺乳头状癌超声特征与颈部淋巴结转移在常规超声及超声造影上的相关性分析
Front Oncol. 2021 Dec 23;11:794399. doi: 10.3389/fonc.2021.794399. eCollection 2021.
7
Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.基于术前血清甲状腺球蛋白和甲状腺乳头状癌临床特征的列线图模型预测颈部淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 15;13:937049. doi: 10.3389/fendo.2022.937049. eCollection 2022.
8
Hashimoto's Thyroiditis Is Associated With Central Lymph Node Metastasis in Classical Papillary Thyroid Cancer: Analysis from a High-Volume Single-Center Experience.桥本甲状腺炎与经典型甲状腺乳头状癌中央区淋巴结转移相关:来自大容量单中心经验的分析。
Front Endocrinol (Lausanne). 2022 May 20;13:868606. doi: 10.3389/fendo.2022.868606. eCollection 2022.
9
A miRNA-clinicopathological nomogram for the prediction of central lymph node metastasis in papillary thyroid carcinoma-analysis from TCGA database.一种用于预测甲状腺乳头状癌中央淋巴结转移的miRNA-临床病理列线图——来自TCGA数据库的分析
Medicine (Baltimore). 2020 Aug 28;99(35):e21996. doi: 10.1097/MD.0000000000021996.
10
A prediction model incorporating the BRAF protein status for determining the risk of cervical lateral lymph node metastasis in papillary thyroid cancer patients with central lymph node metastasis.一种纳入BRAF蛋白状态的预测模型,用于确定伴有中央淋巴结转移的甲状腺乳头状癌患者发生颈侧方淋巴结转移的风险。
Eur J Surg Oncol. 2021 Nov;47(11):2774-2780. doi: 10.1016/j.ejso.2021.08.033. Epub 2021 Aug 27.

引用本文的文献

1
Correlation of multiple peripheral blood parameters with metastasis and invasion of papillary thyroid cancer: a retrospective cohort study.多种外周血参数与甲状腺乳头状癌转移和侵袭的相关性:一项回顾性队列研究
Endocrine. 2025 Jun;88(3):757-765. doi: 10.1007/s12020-025-04194-y. Epub 2025 Mar 1.
2
Optimal surgical population for cervical lymph node dissection in PTC.甲状腺乳头状癌中进行颈淋巴结清扫的最佳手术人群。
Front Oncol. 2024 Apr 5;14:1280607. doi: 10.3389/fonc.2024.1280607. eCollection 2024.
3
Prediction model of cervical lymph node metastasis based on clinicopathological characteristics of papillary thyroid carcinoma: a dual-center retrospective study.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights.C 反应蛋白与癌症——诊断与治疗新视角。
Front Immunol. 2020 Nov 19;11:595835. doi: 10.3389/fimmu.2020.595835. eCollection 2020.
3
Machine Learning Algorithms for the Prediction of Central Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.
基于甲状腺乳头状癌临床病理特征的颈淋巴结转移预测模型:一项双中心回顾性研究。
Front Endocrinol (Lausanne). 2023 Sep 11;14:1233929. doi: 10.3389/fendo.2023.1233929. eCollection 2023.
4
Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation.在降阶梯治疗时代,预防性中央区颈部淋巴结清扫术在甲状腺乳头状癌中的作用。
World J Clin Oncol. 2023 Jul 24;14(7):247-258. doi: 10.5306/wjco.v14.i7.247.
机器学习算法在预测甲状腺乳头状癌患者中央淋巴结转移中的应用。
Front Endocrinol (Lausanne). 2020 Oct 21;11:577537. doi: 10.3389/fendo.2020.577537. eCollection 2020.
4
Plasma Fibrinogen Predicts the Prognosis of Bladder Cancer Patients After Radical Cystectomy.血浆纤维蛋白原可预测膀胱癌患者根治性膀胱切除术后的预后。
Cancer Manag Res. 2020 Sep 29;12:9303-9314. doi: 10.2147/CMAR.S269244. eCollection 2020.
5
Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.血小板-淋巴细胞比值(PLR)在胃癌中的临床病理和预后意义:一项更新的荟萃分析。
World J Surg Oncol. 2020 Jul 30;18(1):191. doi: 10.1186/s12957-020-01952-2.
6
Neutrophil-lymphocyte ratio associated with poor prognosis in oral cancer: a retrospective study.中性粒细胞与淋巴细胞比值与口腔癌预后不良相关:一项回顾性研究。
BMC Cancer. 2020 Jun 17;20(1):568. doi: 10.1186/s12885-020-07063-1.
7
The role of neutrophil death in chronic inflammation and cancer.中性粒细胞死亡在慢性炎症和癌症中的作用。
Cell Death Discov. 2020 Apr 22;6:26. doi: 10.1038/s41420-020-0255-6. eCollection 2020.
8
Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer.术前血浆纤维蛋白原和 D-二聚体作为非肌层浸润性膀胱癌的预后生物标志物。
Clin Genitourin Cancer. 2020 Feb;18(1):11-19.e1. doi: 10.1016/j.clgc.2019.10.025. Epub 2019 Nov 6.
9
Clinicopathological and prognostic value of preoperative plasma fibrinogen in gastric cancer patients: A meta-analysis.胃癌患者术前血浆纤维蛋白原的临床病理特征及预后价值:一项荟萃分析
Medicine (Baltimore). 2019 Oct;98(40):e17310. doi: 10.1097/MD.0000000000017310.
10
Inflammation and Cancer: Triggers, Mechanisms, and Consequences.炎症与癌症:触发因素、机制与后果。
Immunity. 2019 Jul 16;51(1):27-41. doi: 10.1016/j.immuni.2019.06.025.